Literature DB >> 24515295

Can leg ulcer fibroblasts phenotype be influenced by human amniotic membrane extract?

H Tauzin1, S Robin, P Humbert, C Viennet, P Saas, C Courderot-Masuyer, P Muret.   

Abstract

Prevalence of leg ulcer in general population is important and new efficient treatments are now needed, especially for chronic leg ulcers. Human amniotic membrane (HAM) can be used as an alternative treatment for recalcitrant leg ulcers. The aim of this study is to investigate the effects of a HAM extract on normal fibroblasts (NF) and ulcer fibroblasts (UF). NF and UF were obtained from biopsies by explants technique. HAM extract was used at 10 μg of total proteins per ml. Single patient-matched NF and UF were compared, without or with HAM extract. Studied parameters were proliferation rate, retraction of free-floating lattices, alpha smooth muscle actin expression by flow cytometry, and synthesis of elastin, glycosaminoglycans (GAGs), pro-collagen I, MMP-1 and TIMP-1. Our results show that UF had a specific phenotype compared to NF: low proliferation, high expression of alpha-SM actin and high synthesis of MMP-1, TIMP-1 and elastin. HAM extract significantly increased the synthesis of GAGs, pro-collagen I and MMP-1 in NF and decreased retraction of free lattices. HAM extract transiently increased UF proliferation, slowed down lattices retraction and decreased elastin synthesis. In conclusion, HAM extract has little effect on UF for the parameters studied and NF are more responsive than UF. However, clinical beneficial effect of HAM application on leg ulcers was previously observed and might rather be related to an action on keratinocytes and/or a modulation of the highly inflammatory environment of these chronic wounds.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515295     DOI: 10.1007/s10561-014-9422-4

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  4 in total

1.  Benefits of cryopreserved human amniotic membranes in association with conventional treatments in the management of full-thickness burns.

Authors:  Anne-Sophie Hatzfeld; Louise Pasquesoone; Nicolas Germain; Pierre-Marie Danzé; Anne-Sophie Drucbert; Meryem Tardivel; Antonino Bongiovanni; Véronique Duquennoy-Martinot; Pierre Guerreschi; Philippe Marchetti
Journal:  Int Wound J       Date:  2019-08-19       Impact factor: 3.315

Review 2.  Protease activity as a prognostic factor for wound healing in venous leg ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Nikki Stubbs; Gill Norman; Jason Kf Wong; Nicky Cullum; Richard D Riley
Journal:  Cochrane Database Syst Rev       Date:  2018-09-01

3.  The effect of amniotic membrane extract on umbilical cord blood mesenchymal stem cell expansion: is there any need to save the amniotic membrane besides the umbilical cord blood?

Authors:  Zahra Vojdani; Ali Babaei; Attiyeh Vasaghi; Mojtaba Habibagahi; Tahereh Talaei-Khozani
Journal:  Iran J Basic Med Sci       Date:  2016-01       Impact factor: 2.699

4.  Development and Characterisation of a Human Chronic Skin Wound Cell Line-Towards an Alternative for Animal Experimentation.

Authors:  Matthew Caley; Ivan B Wall; Matthew Peake; David Kipling; Peter Giles; David W Thomas; Phil Stephens
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.